-
Pfizer's Bold Bid to Conquer Cancer
Post on 8/17/16
-
Immune Pharmaceuticals Provides Business and R&D Update
Post on 8/16/16
-
Arno Completes $2.8 Million Private Placement
Post on 8/16/16
-
Advaxis Secures a $30M Direct Placement Financing to Healthcare Specialist Investors
Post on 8/16/16
-
CHI Franciscan Health and CityMD Open First Urgent Care Center in Seattle
Post on 8/15/16
-
Partnership for a Drug-Free Texas Joins the Partnership for Drug-Free Kids as New National Alliance Partner
Post on 8/15/16
-
Aetna to Narrow Individual Public Exchange Participation
Post on 8/15/16
-
Celsion Corp. Reports Q2 2016 Financial Results and Provides Business Update
Post on 8/15/16
-
How Risky Is Celldex Therapeutics, Inc.?
Post on 8/15/16
-
Bristol-Myers' Revolutionary Cancer Drug Suffers A Big Blow
Post on 8/15/16
-
Echo Therapeutics Announces Second Quarter 2016 Financial Results
Post on 8/14/16
-
After Opdivo's Failure, Is Merck a Better Buy Than Bristol-Myers?
Post on 8/11/16
-
TrialScope Adds Four New Customers to Growing Base
Post on 8/10/16
-
Misonix Announces Agreement with SonoSpine
Post on 8/10/16
-
Fortress Biotech Reports Second Quarter 2016 Financial Results and Recent Corporate Highlights
Post on 8/10/16
-
Agadia Systems Announces Agreement with Serve You Custom Rx Management
Post on 8/9/16
-
U.S. News & World Report Names Hartford Hospital Best in Hartford Metro Region
Post on 8/9/16
-
Eagle Pharmaceuticals Reports Second Quarter 2016 Results
Post on 8/9/16
-
Abeona Therapeutics, EB Research Partnership and EB Medical Research Foundation to Collaborate on Epidermolysis Bullosa Treatments
Post on 8/9/16
-
Bellerophon Provides Business Update
Post on 8/9/16
-
SCYNEXIS Reports Second Quarter 2016 Financial Results and Provides Company Update
Post on 8/8/16
-
Celgene and Novartis Lift Juno Therapeutics' Q2 Results
Post on 8/8/16
-
3 Biotech Stocks to Buy in August
Post on 8/8/16
-
Better Buy: Merck & Co. Inc. vs. Eli Lilly
Post on 8/5/16
-
Palatin Technologies Closes $9.2 Million Financing
Post on 8/4/16
